| NCT ID | NCT07358572 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Friendship Hospital |
| Condition | Chronic Kidney Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2031-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2025-12-01 with a primary completion date of 2031-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the interaction between the eyes, brain, and kidneys in adult patients with Chronic Kidney Disease (CKD). The main question it aims to answer is: Do changes in the brain's network connectivity and the retina's blood vessels correlate with cognitive decline and kidney function in CKD patients? Participants with CKD who are already undergoing clinical care will complete cognitive tests and questionnaires, have non-invasive MRI scans of their brain and kidneys, and undergo non-invasive eye imaging (OCT/OCTA) of their retinas.
Eligibility Criteria
Inclusion Criteria: 1. Aged 18-70 years. 2. Patients clinically diagnosed with CKD stages 1-5. 3. No contraindications for MRI examination (e.g., cardiac pacemaker, claustrophobia, cochlear implant, hearing aid, coronary stents implanted before 2015) and able to complete the MRI scan. Exclusion Criteria: 1. Patients with recent or prior cerebral hemorrhage or cerebral infarction. 2. History of epileptic seizures or psychiatric disorders. 3. Patients with claustrophobia. 4. Pregnant or lactating patients. 5. Presence of other central nervous system diseases (e.g., tumor, trauma). 6. Unstable angina, congestive heart failure (NYHA class III or IV), or acute myocardial infarction. 7. Any systemic or other diseases deemed unsuitable for clinical trial participation.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07358572 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Chronic Kidney Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07358572 currently recruiting?
Yes, NCT07358572 is actively recruiting participants. Contact the research team at wanghao4756@163.com for enrollment information.
Where is the NCT07358572 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07358572 clinical trial?
NCT07358572 is sponsored by Beijing Friendship Hospital. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.